🔎 Trials Near Me

Akèy › Kansè poumon selil ti › Wisconsin

Etid klinik pou Kansè poumon selil ti nan Wisconsin

11 etid pou Kansè poumon selil ti ap chèche patisipan nan sit nan Wisconsin.

Vil nan Wisconsin

Tèks ofisyèl etid la (Anglè)

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

  • University of Wisconsin Carbone Cancer Center, Madison
Ap rekriteFaz 1/2
Laj 12 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT04585750

A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

  • University of Wisconsin /ID# 279909, Madison
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT07365241

A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

  • UW Health Carbone Cancer Center, Madison
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07488676

A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)

  • Medical College of Wisconsin ( Site 1112), Milwaukee
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT06780137

Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer

  • Gundersen, La Crosse
  • Aspirus Cancer Center Wausau, Wausau
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Aug 28, 2026 · NCT07057791

A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer

  • Marshfield Medical Center, Marshfield
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT06095505

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

  • University of Wisconsin- Madison, Madison
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Aug 11, 2026 · NCT05592626

A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer

  • Medical College of Wisconsin, Milwaukee
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 6, 2026 · NCT06203210

Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer

  • University of Wisconsin, Madison
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Apr 8, 2026 · NCT04919382

Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study

  • Duluth Clinic Ashland, Ashland
  • Gundersen Lutheran Medical Center, La Crosse
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Mar 30, 2026 · NCT06769126

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.